Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

J.L. Kuiper; M.I. Ronden; A. Becker; D.A.M. Heideman; P. van Hengel; B. Ylstra; E. Thunnissen; E.F. Smit

doi:https://doi.org/10.1136/jclinpath-2015-202866

Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

J.L. Kuiper, M.I. Ronden, A. Becker, D.A.M. Heideman, P. van Hengel, B. Ylstra, E. Thunnissen, E.F. Smit

Research output: Contribution to journal › Letter › Academic › peer-review

38 Citations (Scopus)

Original language	English
Pages (from-to)	320-321
Number of pages	2
Journal	Journal of clinical pathology
Volume	68
Issue number	4
DOIs	https://doi.org/10.1136/jclinpath-2015-202866
Publication status	Published - 1 Jan 2015

Access to Document

https://doi.org/10.1136/jclinpath-2015-202866

Cite this

@article{069b710cc69442c6ad7bd837e64cc683,

title = "Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor",

author = "J.L. Kuiper and M.I. Ronden and A. Becker and D.A.M. Heideman and {van Hengel}, P. and B. Ylstra and E. Thunnissen and E.F. Smit",

year = "2015",

month = jan,

day = "1",

doi = "https://doi.org/10.1136/jclinpath-2015-202866",

language = "English",

volume = "68",

pages = "320--321",

journal = "Journal of clinical pathology",

issn = "0021-9746",

publisher = "BMJ Publishing Group",

number = "4",

}

TY - JOUR

T1 - Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

AU - Kuiper, J.L.

AU - Ronden, M.I.

AU - Becker, A.

AU - Heideman, D.A.M.

AU - van Hengel, P.

AU - Ylstra, B.

AU - Thunnissen, E.

AU - Smit, E.F.

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84925014156&partnerID=8YFLogxK

U2 - https://doi.org/10.1136/jclinpath-2015-202866

DO - https://doi.org/10.1136/jclinpath-2015-202866

M3 - Letter

C2 - 25661795

SN - 0021-9746

VL - 68

SP - 320

EP - 321

JO - Journal of clinical pathology

JF - Journal of clinical pathology

IS - 4

ER -

Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

Access to Document

Other files and links

Cite this